![Jonathan Drachman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jonathan Drachman
Plus aucun poste en cours
Profil
Jonathan G.
Drachman formerly worked at Aquinox Pharmaceuticals, Inc., as Chairman & Chief Executive Officer, Neoleukin Therapeutics, Inc., as Chief Executive Officer, Neoleukin Therapeutics, Inc., as President, Chief Executive Officer, CFO & Director from 2022 to 2023, Bloodworks Northwest, as Medical Director-Umbilical Cord Blood Program, Calithera Biosciences, Inc., as Independent Director from 2013 to 2022, Harpoon Therapeutics, Inc., as Independent Director from 2018 to 2024, Seagen, Inc., as Chief Medical Officer, EVP-Research & Development from 2013 to 2018, and the University of Washington, as Clinical Professor-Medicine from 1998 to 2004.
Dr. Drachman received his undergraduate degree from Harvard University and doctorate degree from Harvard Medical School.
Anciens postes connus de Jonathan Drachman
| Sociétés | Poste | Fin |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/03/2024 |
| NEUROGENE INC. | Directeur Général | 31/03/2023 |
| CALITHERA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/06/2022 |
| SEAGEN INC. | Directeur Technique/Scientifique/R&D | 17/05/2018 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2004 |
Formation de Jonathan Drachman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bloodworks Northwest
 Bloodworks Northwest Medical/Nursing ServicesHealth Services Provides Blood and tissue services | Health Services |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Calithera Biosciences, Inc.
 Calithera Biosciences, Inc. BiotechnologyHealth Technology Develops novel therapeutics to control cancer and other diseases | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Choisissez Zonebourse 
